Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KRT8 Antikörper (CF®647)

Der Maus Monoklonal Anti-KRT8-Antikörper wurde für IF und FACS validiert. Er ist geeignet, KRT8 in Proben von Human, Rind (Kuh), Kaninchen, Schwein und Schaf zu detektieren.
Produktnummer ABIN6178828

Kurzübersicht für KRT8 Antikörper (CF®647) (ABIN6178828)

Target

Alle KRT8 Antikörper anzeigen
KRT8 (Keratin 8 (KRT8))

Reaktivität

  • 314
  • 89
  • 78
  • 66
  • 64
  • 62
  • 61
  • 16
  • 14
  • 10
  • 8
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Human, Rind (Kuh), Kaninchen, Schwein, Schaf

Wirt

  • 168
  • 163
  • 3
Maus

Klonalität

  • 184
  • 147
  • 1
Monoklonal

Konjugat

  • 173
  • 27
  • 17
  • 12
  • 9
  • 8
  • 8
  • 8
  • 8
  • 8
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser KRT8 Antikörper ist konjugiert mit CF®647

Applikation

  • 240
  • 176
  • 123
  • 88
  • 71
  • 49
  • 48
  • 42
  • 41
  • 40
  • 37
  • 29
  • 22
  • 5
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS)

Klon

B22-1
  • Verwendungszweck

    Mouse Monoclonal anti-Cytokeratin 8 (B22.1), CF647 Conjugate

    Produktmerkmale

    Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (?ring-like, perinuclear?) from ductal (?peripheral-predominant?) carcinoma of the breast. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogen

    Cytoskeletal preparation from HeLa cells

    Isotyp

    IgG2a kappa
  • Applikationshinweise

    Does not react with mouse, rat, chicken or Xenopus, others not known
    • Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Immunofluorescence 1-2 μg/mL

    Kommentare

    MCF-7 or A431 cells. Skin, Colon, lung or breast carcinoma

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    100 μg/mL

    Buffer

    PBS/0.1 % BSA/0.05 % azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Protect from light
  • Target

    KRT8 (Keratin 8 (KRT8))

    Andere Bezeichnung

    Cytokeratin 8

    Hintergrund

    CARD2, CK8, CYK8, CYKER, Cytokeratin Endo A, DreK8, EndoA, K2C8, K8, Keratin 8, Krt 2.8, KRT8, Type-II Keratin Kb8

    Molekulargewicht

    52.5 kDa

    Gen-ID

    3856

    UniProt

    P05787
Sie sind hier:
Chat with us!